We have located links that may give you full text access.
Journal Article
Research Support, Non-U.S. Gov't
Open-loop control of the biomass concentration within the growth phase of recombinant protein production processes.
Journal of Biotechnology 2006 December 16
Recombinant protein production processes are typically divided into two phases. In the first one, pure cell propagation takes place, while in the second one product formation is switched on within the cells by adding an inducer. In the initial biomass formation phase, the cell density is rather low and, hence, the measurement quantities that could be used to determine the process' state depict small values and are rather severely distorted by measurement noise. Because of these measurement problems, the fermentation cannot be reliably controlled by feedback control during this first production phase; instead, the process must be controlled in an open-loop fashion. The consequence, worked out in this paper, is to design substrate feed rate profiles for the growth phase in such a way that they are robust with respect to the main disturbances observed in practice. The robustness of the biomass formation is shown to be primarily dependent on the specific growth rate adjusted in the first hours. High batch-to-batch reproducibility can be obtained with exponential feeding profiles F(t) corresponding to specific growth rates micro(set) well below the maximal specific growth rate micro(max) of the organism. The reduction in the growth rate needed to obtain a robust process behavior depends on the inaccuracies in the initial biomass concentrations. Quantitative feed rate profiles were obtained by numerical simulation and these results were validated experimentally by means of a series of cultivation runs, where a recombinant pharmaceutical protein was produced. All experimental data confirmed the assumptions made in the robust process design study.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app